HomeKB7 • FRA
add
Solventum Corp
Previous close
€66.40
Day range
€64.80 - €65.40
Year range
€43.00 - €80.50
Market cap
13.58B USD
Avg Volume
47.00
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 2.07B | 2.68% |
Operating expense | 964.00M | 21.87% |
Net income | 137.00M | -42.19% |
Net profit margin | 6.62 | -43.71% |
Earnings per share | 1.34 | -35.58% |
EBITDA | 289.00M | -44.42% |
Effective tax rate | -260.53% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 534.00M | -46.39% |
Total assets | 14.53B | -1.25% |
Total liabilities | 11.26B | 3.73% |
Total equity | 3.26B | — |
Shares outstanding | 173.01M | — |
Price to book | 3.52 | — |
Return on assets | 2.76% | — |
Return on capital | 3.58% | — |
Cash Flow
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | 137.00M | -42.19% |
Cash from operations | 29.00M | -93.44% |
Cash from investing | -114.00M | -11.76% |
Cash from financing | -139.00M | -130.09% |
Net change in cash | -228.00M | -128.43% |
Free cash flow | 122.00M | -67.18% |
About
Solventum Corporation is an American health care company that was spun off from 3M on April 1, 2024. Wikipedia
Founded
2023
Headquarters
Website
Employees
22,000